Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease

Biomed Res Int. 2019 Jan 2:2019:8507583. doi: 10.1155/2019/8507583. eCollection 2019.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a common, multifactorial, and poorly understood liver disease whose incidence is globally rising. During the past decade, several lines of evidence suggest that dysbiosis of intestinal microbiome represents an important factor contributing to NAFLD occurrence and its progression into NASH. The mechanisms that associate dysbiosis with NAFLD include changes in microbiota-derived mediators, deregulation of the gut endothelial barrier, translocation of mediators of dysbiosis, and hepatic inflammation. Changes in short chain fatty acids, bile acids, bacterial components, choline, and ethanol are the result of altered intestinal microbiota. We perform a narrative review of the previously published evidence and discuss the use of gut microbiota-derived mediators as potential markers in NAFLD.

Publication types

  • Review

MeSH terms

  • Animals
  • Bile Acids and Salts / metabolism
  • Biomarkers / metabolism*
  • Fatty Acids, Volatile / metabolism
  • Gastrointestinal Microbiome / physiology*
  • Humans
  • Non-alcoholic Fatty Liver Disease / metabolism*
  • Non-alcoholic Fatty Liver Disease / microbiology*

Substances

  • Bile Acids and Salts
  • Biomarkers
  • Fatty Acids, Volatile